Jackie and Jill: Talking About JAK Inhibitors While Caring for RA Patients

Learn how JAK inhibitors can help patients with rheumatoid arthritis achieve better outcomes.




In this course, you will receive sound scientific evidence to help pharmacists better understand benefits and risks associated with JAK inhibitors and information and practical tools to promote patient engagement in his/her treatment and help them better understand benefits and risks associated with JAK inhibitors

This learning activity has received financial support from Abbvie in the form of an unrestricted educational grant.

Learning objectives:

Following participation in this learning activity,
pharmacists will be better able to:

  • Discuss practical considerations regarding the treatment monitoring and follow-up of patients treated with JAK Inhibitors
  • Counsel patients effectively on targeted-synthetic therapy, including safety and efficacy considerations
  • Describe the role of pharmacists in providing care to patients on JAK inhibitor therapy

Course outline:

  • Webinar Recording - 1 hour
  • Program Evaluation - 15 minutes


Course at a glance:

  • 1.25 hours to complete
  • Available until September 21, 2023
  • Online
  • Completion requirement: Watch the course recording and complete the course feedback.

Who should take this course:

Pharmacists who want to improve their knowledge of JAK inhibitor therapies.

Development Team:

  • Michael Boivin, BSc. Pharm